Multiple endocrine neoplasia type 1 with concurrent Cushing's disease, prolactinoma, and multifocal pancreatic neuroendocrine tumors including insulinoma: a case report. [PDF]
Ups J Med Scida Silva BT +5 more
europepmc +1 more source
The clinical value of [<sup>18</sup>F]-fluoro-ethyl-L-tyrosine PET ([<sup>18</sup>F]FET-PET) correlated with MRI in patients with functioning pituitary adenomas: an observational cohort study. [PDF]
Pituitaryvan der Hoeven LS +9 more
europepmc +1 more source
Widespread invasion of a giant prolactinoma via valveless venous channels: illustrative case. [PDF]
J Neurosurg Case LessonsLiang AS +4 more
europepmc +1 more source
Multivessel spontaneous coronary artery dissection in a young woman using cabergoline. [PDF]
Endocrinol Diabetes Metab Case RepByrne R, Shiels P, Kumar R.
europepmc +1 more source
[Impulse control disorder: patients with pituitary adenomas and dopaminergic agonists]. [PDF]
Rev Med Inst Mex Seguro SocBarreras-Ruíz A +4 more
europepmc +1 more source
Dopamine Agonist Therapy Induced Fatal Pneumocephalus in Giant Prolactinoma. [PDF]
JCEM Case RepM H A +5 more
europepmc +1 more source
Cystic versus non-cystic prolactinoma: clinical, hormonal, radiological, and remission outcomes in Basrah. [PDF]
Front Endocrinol (Lausanne)Reman KA +4 more
europepmc +1 more source
Long-term cabergoline use does not predict degree of prolactinoma fibrosis nor significantly impact surgical outcomes. [PDF]
PituitaryMamelak AN +9 more
europepmc +1 more source
circOMA1 delivered by exosomes regulates DRD2‑mediated prolactinoma resistance. [PDF]
Int J Mol MedRao Q +9 more
europepmc +1 more source